X0306 4 2021-02-09 0 0000874866 CORVEL CORP CRVL 0001450607 BLAHA DIANE 1920 MAIN STREET, SUITE 900 IRVINE CA 92614 0 1 0 0 Chief Marketing Officer Common Stock 2021-02-09 4 M 0 1500 59.32 A 6598 D Common Stock 2021-02-09 4 S 0 1500 105.8012 D 5098 D Common Stock 2021-02-09 4 M 0 1232 59.32 A 6330 D Common Stock 2021-02-09 4 S 0 1232 105.8012 D 5098 D Common Stock 2021-02-09 4 M 0 625 57.35 A 5723 D Common Stock 2021-02-09 4 S 0 625 105.8012 D 5098 D Common Stock 2021-02-09 4 M 0 1042 49.4 A 6140 D Common Stock 2021-02-09 4 S 0 1042 105.8012 D 5098 D Common Stock 2021-02-09 4 M 0 1267 57.75 A 6365 D Common Stock 2021-02-09 4 S 0 1267 105.8012 D 5098 D Common Stock 2021-02-09 4 M 0 1250 48.35 A 6348 D Common Stock 2021-02-09 4 S 0 1250 105.8012 D 5098 D Common Stock 2021-02-09 4 M 0 833 45.9 A 5931 D Common Stock 2021-02-09 4 S 0 833 105.8012 D 5098 D Common Stock 2021-02-09 4 M 0 42 43.32 A 5140 D Common Stock 2021-02-09 4 S 0 42 105.8012 D 5098 D Common Stock 2021-02-09 4 M 0 83 45.73 A 5181 D Common Stock 2021-02-09 4 S 0 83 105.8012 D 5098 D Non-Qualified Stock Option (right to buy) 43.32 2021-02-09 4 M 0 42 0.0 D 2021-08-04 Common Stock 42 0 D Non-Qualified Stock Option (right to buy) 45.73 2021-02-09 4 M 0 83 0.0 D 2021-05-05 Common Stock 83 0 D Non-Qualified Stock Option (right to buy) 45.9 2021-02-09 4 M 0 833 0.0 D 2022-05-04 Common Stock 833 125 D Non-Qualified Stock Option (right to buy) 48.35 2021-02-09 4 M 0 1250 0.0 D 2022-08-03 Common Stock 1250 375 D Non-Qualified Stock Option (right to buy) 49.4 2021-02-09 4 M 0 1042 0.0 D 2023-05-03 Common Stock 1042 781 D Non-Qualified Stock Option (right to buy) 57.35 2021-02-09 4 M 0 625 0.0 D 2023-08-02 Common Stock 625 375 D Non-Qualified Stock Option (right to buy) 57.75 2021-02-09 4 M 0 1267 0.0 D 2022-11-02 Common Stock 1267 0 D Non-Qualified Stock Option (right to buy) 59.32 2021-02-09 4 M 0 1500 0.0 D 2023-11-01 Common Stock 1500 3632 D Non-Qualified Stock Option (right to buy) 59.32 2021-02-09 4 M 0 1232 0.0 D 2023-11-01 Common Stock 1232 2400 D Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Option will vest based on achievement of certain performance criteria relating to earnings growth. By: Sharon O'Connor For: Diane Blaha 2021-02-11